Prestige Consumer Healthcare, Inc. (PBH)
45.26
+0.49
(+1.09%)
USD |
NYSE |
Oct 02, 16:00
45.28
+0.02
(+0.04%)
Pre-Market: 20:00
Prestige Consumer Healthcare Price to Book Value : 1.119 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.119 |
| October 01, 2026 | 1.106 |
| September 30, 2026 | 1.134 |
| September 29, 2026 | 1.155 |
| September 28, 2026 | 1.160 |
| September 25, 2026 | 1.152 |
| September 24, 2026 | 1.128 |
| September 23, 2026 | 1.135 |
| September 22, 2026 | 1.180 |
| September 21, 2026 | 1.157 |
| September 18, 2026 | 1.111 |
| September 17, 2026 | 1.148 |
| September 16, 2026 | 1.158 |
| September 15, 2026 | 1.154 |
| September 14, 2026 | 1.177 |
| September 11, 2026 | 1.160 |
| September 10, 2026 | 1.17 |
| September 09, 2026 | 1.204 |
| September 08, 2026 | 1.231 |
| September 04, 2026 | 1.292 |
| September 03, 2026 | 1.299 |
| September 02, 2026 | 1.306 |
| September 01, 2026 | 1.301 |
| August 31, 2026 | 1.280 |
| August 28, 2026 | 1.297 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.266 |
| August 26, 2026 | 1.289 |
| August 25, 2026 | 1.272 |
| August 24, 2026 | 1.286 |
| August 21, 2026 | 1.268 |
| August 20, 2026 | 1.249 |
| August 19, 2026 | 1.277 |
| August 18, 2026 | 1.250 |
| August 17, 2026 | 1.237 |
| August 14, 2026 | 1.270 |
| August 13, 2026 | 1.268 |
| August 12, 2026 | 1.292 |
| August 11, 2026 | 1.325 |
| August 10, 2026 | 1.310 |
| August 07, 2026 | 1.356 |
| August 06, 2026 | 1.345 |
| August 05, 2026 | 1.309 |
| August 04, 2026 | 1.285 |
| August 03, 2026 | 1.283 |
| July 31, 2026 | 1.241 |
| July 30, 2026 | 1.234 |
| July 29, 2026 | 1.290 |
| July 28, 2026 | 1.278 |
| July 27, 2026 | 1.246 |
| July 24, 2026 | 1.227 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.390 |
| Structure Therapeutics, Inc. | 1.455 |
| ANI Pharmaceuticals, Inc. | 2.776 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
Price to Book Value Related Metrics
| PE Ratio | 12.67 |
| PS Ratio | 1.973 |
| Price to Free Cash Flow | 9.261 |
| Price | 45.26 |
| Earnings Yield | 7.89% |
| Market Cap | 2.144B |
| Operating PE Ratio | 7.512 |
| Normalized PE Ratio | 12.67 |